Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.Excessive prolonged use of topical corticosteroids can suppress pituitary-adrenal functions resulting in secondary adrenal insufficiency, and produce manifestations of hypercorticism, including Cushing's Treatment: Appropriate symptomatic treatment is indicated. Ask your pharmacist how to Do not use this scalp application on your child's scalp for more than 5 days. Manifestations of adrenal suppression in children include low plasma cortisol levels and absence of response to ACTH stimulation. Most people find that when the scalp application is used correctly, it does not cause any problems. Keep this medicine out of the sight and reach of children. This medicine has been prescribed for you only. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possiblecauses of visual disturbances which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical Paediatric population: Paediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalamic-pituary-adrenal (HPA) axis suppression and to exogenous corticosteroid effects than mature patients because of greater absorption due to a large skin surface area to body weight ratio.HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Do not use Diprosalic Scalp Application after the expiry date which is stated on the carton and bottle after EXP. If you (or somebody else) accidentally swallows the scalp application, it should not cause any problems. Drugs of this class should not be used extensively in large amounts or for prolonged periods of time in Since it is not known whether topical administration of corticosteroids can result in sufficient systemic absorption to produce detectable quantities in breast milk, a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.Diprosalic skin preparations are generally well tolerated and side-effects are rare.Continuous application without interruption may result in local atrophy of the skin, striae and superficial Adverse reactions that have been reported with the use of topical corticosteroids include: burning, itching,irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis The following may occur more frequently with the use of occlusive dressings: maceration of the skin, secondary infection, skin atrophy, striae and miliaria.Vision blurred (see also section 4.4) has been reported with corticosteroid use (frequency not known).In addition, prolonged use of salicylic acid preparations may cause dermatitis.Reporting suspected adverse reactions after authorisation of the medicinal product is important.

Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.Excessive prolonged use of topical corticosteroids can suppress pituitary-adrenal functions resulting in secondary adrenal insufficiency, and produce manifestations of hypercorticism, including Cushing's Treatment: Appropriate symptomatic treatment is indicated. Ask your pharmacist how to Do not use this scalp application on your child's scalp for more than 5 days. Manifestations of adrenal suppression in children include low plasma cortisol levels and absence of response to ACTH stimulation. Most people find that when the scalp application is used correctly, it does not cause any problems. Keep this medicine out of the sight and reach of children. This medicine has been prescribed for you only. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possiblecauses of visual disturbances which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical Paediatric population: Paediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalamic-pituary-adrenal (HPA) axis suppression and to exogenous corticosteroid effects than mature patients because of greater absorption due to a large skin surface area to body weight ratio.HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Do not use Diprosalic Scalp Application after the expiry date which is stated on the carton and bottle after EXP. If you (or somebody else) accidentally swallows the scalp application, it should not cause any problems. Drugs of this class should not be used extensively in large amounts or for prolonged periods of time in Since it is not known whether topical administration of corticosteroids can result in sufficient systemic absorption to produce detectable quantities in breast milk, a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.Diprosalic skin preparations are generally well tolerated and side-effects are rare.Continuous application without interruption may result in local atrophy of the skin, striae and superficial Adverse reactions that have been reported with the use of topical corticosteroids include: burning, itching,irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis The following may occur more frequently with the use of occlusive dressings: maceration of the skin, secondary infection, skin atrophy, striae and miliaria.Vision blurred (see also section 4.4) has been reported with corticosteroid use (frequency not known).In addition, prolonged use of salicylic acid preparations may cause dermatitis.Reporting suspected adverse reactions after authorisation of the medicinal product is important.

Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.Excessive prolonged use of topical corticosteroids can suppress pituitary-adrenal functions resulting in secondary adrenal insufficiency, and produce manifestations of hypercorticism, including Cushing's Treatment: Appropriate symptomatic treatment is indicated. Ask your pharmacist how to Do not use this scalp application on your child's scalp for more than 5 days. Manifestations of adrenal suppression in children include low plasma cortisol levels and absence of response to ACTH stimulation. Most people find that when the scalp application is used correctly, it does not cause any problems. Keep this medicine out of the sight and reach of children. This medicine has been prescribed for you only. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possiblecauses of visual disturbances which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical Paediatric population: Paediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hypothalamic-pituary-adrenal (HPA) axis suppression and to exogenous corticosteroid effects than mature patients because of greater absorption due to a large skin surface area to body weight ratio.HPA axis suppression, Cushing's syndrome, linear growth retardation, delayed weight gain, and intracranial hypertension have been reported in children receiving topical corticosteroids. Do not use Diprosalic Scalp Application after the expiry date which is stated on the carton and bottle after EXP. If you (or somebody else) accidentally swallows the scalp application, it should not cause any problems. Drugs of this class should not be used extensively in large amounts or for prolonged periods of time in Since it is not known whether topical administration of corticosteroids can result in sufficient systemic absorption to produce detectable quantities in breast milk, a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.Diprosalic skin preparations are generally well tolerated and side-effects are rare.Continuous application without interruption may result in local atrophy of the skin, striae and superficial Adverse reactions that have been reported with the use of topical corticosteroids include: burning, itching,irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis The following may occur more frequently with the use of occlusive dressings: maceration of the skin, secondary infection, skin atrophy, striae and miliaria.Vision blurred (see also section 4.4) has been reported with corticosteroid use (frequency not known).In addition, prolonged use of salicylic acid preparations may cause dermatitis.Reporting suspected adverse reactions after authorisation of the medicinal product is important.